95
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Faecal immunochemical testing (FIT): sources of result variation based on three years of routine testing of symptomatic patients in English primary care

, , , , , , & show all
Pages 211-217 | Received 17 Jan 2021, Accepted 24 Feb 2021, Published online: 19 Mar 2021

References

  • World Health Organization. Colorectal cancer source: Globocan 2018 number of new cases in 2018, both sexes, all ages [Internet]; 2018. [cited 2019 May 30]. Available from: http://gco.iarc.fr/today/data/factsheets/cancers/10_8_9-Colorectum-fact-sheet.pdf
  • Wilkins T, McMechan D, Talukder A. Colorectal cancer screening and prevention. Am Fam Physician. 2018;97:658–665.
  • Allison JE, Fraser CG, Halloran SP, et al. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014;8:117–130.
  • [cited 2020 Dec 28]. Available from: https://www.nhs.uk/conditions/bowel-cancer-screening
  • National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NICE guideline (NG12); 2017. [updated 2020 Sept 11] [cited 2020 Dec 28]. Available from: https://www.nice.org.uk/guidance/ng12
  • National Institute for Health and Care Excellence. Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary car. Diagnostics guidance (DG30); 2017. [cited 2020 Dec 28]. Available from: https://www.nice.org.uk/guidance/dg30
  • Mole G, Withington J, Logan R. From FOBt to FIT: making it work for patients and populations. Clin Med. 2019;19:196–199.
  • [Accessed 2020 Dec 28]. Available from: https://www.nice.org.uk/Media/Default/About/COVID-19/Specialty-guides/triaging-patients-with-lower-gi-symptoms.pdf
  • Rees CJ, East JE, Oppong K, et al. Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: guidance from the British society of gastroenterology. Clin Med (Lond). 2020;20:352–358.
  • Fraser CG. Faecal occult blood tests- eliminate, enhance or update? Ann Clin Biochem. 2008;45:117–121.
  • Nicholson BD, James T, East JE, et al. Experience of adopting faecal immunochemical testing to meet the NICE colorectal cancer referral criteria for low-risk symptomatic primary care patients in Oxfordshire, UK. Frontline Gastroenterol. 2018;10:347–355.
  • Nicholson BD, James T, Paddon M, et al. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests. Aliment Pharmacol Ther. 2020;52:1031–1041.
  • Fraser CG, Benton SC. Detection capability of quantitative faecal immunochemical tests for haemoglobin (FIT) and reporting of low faecal haemoglobin concentrations. Clin Chem Lab Med. 2019;57:611–616.
  • Godber IM, Benton SC, Fraser CG. Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints. J Clin Pathol. 2018;71:1041–1045.
  • Carroll MRR, Piggott C, Pearson S, et al. Evaluation of quantitative faecal immunochemical tests for haemoglobin. Guildford, UK: Guildford Medical Device Evaluation Centre (GMEC); 2013.
  • Brown LF, Fraser CG. Effect of delay in sampling on haemoglobin determined by faecal immunochemical tests. Ann Clin Biochem. 2008;45:604–605.
  • Steele R, Forgacs I, McCreanor G, et al. Use of faecal occult blood tests in symptomatic patients. BMJ. 2015;351:h4256.
  • Hamilton W, Hajioff S, Graham J, et al. Authors’ reply to Steele and colleagues. BMJ. 2015;351:h4258.
  • Linnet K, Kondratovich M. Partly nonparametric approach for determining the limit of detection. Clin Chem. 2004;50:732–740.
  • Nicholson BD, Oke J, Friedemann Smith C, et al. The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer. BMJ Open. 2018;8:e018168.
  • D’Souza N, Delisle T, Chen M, et al., NICE FIT Steering Group. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut. 2020 Oct 21:gutjnl-2020-321956. DOI:https://doi.org/10.1136/gutjnl-2020-321956
  • Gratton J, Phetcharaburanin J, Mullish BH, et al. Optimized sample handling strategy for metabolic profiling of human feces. Anal Chem. 2016;88:4661–4668.
  • Turvill J, Mellen S, Jeffery L, et al. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer. Scand J Gastroenterol. 2018;53:1526–1534.
  • Auge JM, Fraser CG, Rodriguez C, et al. Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients. Clin Chem Lab Med. 2016;54:125–132.
  • Chapman C, Bunce J, Oliver S, et al. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer. BJS Open. 2019;3:395–402.
  • Blake MR, Raker JM, Whelan K. Validity and reliability of the Bristol stool form scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2016;44:693–703.
  • Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong Cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81–95.
  • Benton SC, Symonds E, Djedovic N, et al. International Federation of Clinical Chemistry Faecal Immunochemical Test Working Group (IFCC FIT-WG). Faecal immunochemical tests for haemoglobin: analytical challenges and potential solutions. Clin Chim Acta. 2021 Feb 8; S0009-8981(21)00040–1. DOI:https://doi.org/10.1016/j.cca.2021.01.024.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.